Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres.
Abstract
The selective 5-HT₁ receptor agonist sumatriptan is an effective therapeutic for migraine pain yet the antimigraine mechanisms of action remain controversial. Pain-responsive fibres containing calcitonin gene-related peptide (CGRP) densely innervating the cranial dura mater are widely believed to be an essential anatomical substrate for the development of migraine pain. 5-HT₁ receptors in the dura colocalize with CGRP fibres in high density and thus provide a possible peripheral site of action for sumatriptan. In the present study, we used high-resolution optical imaging selectively within individual mouse dural CGRP nociceptive fibre terminations and found that application of sumatriptan caused a rapid, reversible dose-dependent inhibition in the amplitude of single action potential evoked Ca²⁺ transients. Pre-application of the 5-HT₁ antagonist GR 127935 or the selective 5-HT(1D) antagonist BRL 15572 prevented inhibition while the selective 5-HT(1B) antagonist SB 224289 did not, suggesting this effect was mediated selectively through the 5-HT(1D) receptor subtype. Sumatriptan inhibition of the action potential evoked Ca²⁺ signaling was mediated selectively through N-type Ca²⁺ channels. Although the T-type Ca²⁺ channel accounted for a greater proportion of the Ca²⁺ signal it did not mediate any of the sumatriptan inhibition. Our findings support a peripheral site of action for sumatriptan in inhibiting the activity of dural pain fibres selectively through a single Ca²⁺ channel subtype. This finding adds to our understanding of the mechanisms that underlie the clinical effectiveness of 5-HT₁ receptor agonists such as sumatriptan and may provide insight for the development of novel peripherally targeted therapeutics for mitigating the pain of migraine.
Links
Authors
Baillie LD, Ahn AH, Mulligan SJ
Institution
Department of Physiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. ldb874@mail.usask.ca
Source
Neuropharmacology 63:3 2012 Sep pg 362-7MeSH
Action PotentialsAnimals
Calcitonin Gene-Related Peptide
Calcium Channel Blockers
Calcium Channels, N-Type
Calcium Signaling
Dura Mater
Electric Stimulation
Immunohistochemistry
Mice
Mice, Transgenic
Microscopy, Fluorescence
Nerve Fibers
Pain
Presynaptic Terminals
Serotonin 5-HT1 Receptor Agonists
Serotonin 5-HT1 Receptor Antagonists
Serotonin Receptor Agonists
Sumatriptan
Pub Type(s)
Journal ArticleResearch Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
22691374
Log In

